- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Sunovion admitted failing to disclose 2016 support to a patient organisation and gave inaccurate information to the PMCPA. Breaches of Clauses 27.7,…
Intercompany complaint about alleged off-label promotion and misleading claims for dolutegravir regimens at an HIV conference and on a website. Panel ruled…
A Frankfurt “faculty” meeting was presented as non-promotional, but invitees weren’t clearly told it was speaker training. Slides and narrative positioned Zydelig…
A BMJ hosted “panel” linking to an Invokana microsite was ruled promotional in its own right. Because it lacked a clear, prominent…
Feraccru website: “well tolerated” claim upheld, but mechanism-of-action text misled by implying human/Feraccru data and a public-facing disease page linked to the…
Chiesi’s NHS “therapeutic review” support was found to facilitate switching to a limited list of products. The Appeal Board upheld breaches of…
Patients attended a restaurant promotional meeting where Multaq was promoted. PMCPA ruled advertising a POM to the public (Clause 22.1) and poor…
A GP said Bydureon prescribing information was “incredibly difficult to read”. Panel found it was near the limit (grey on white) but…
A PCT complained that Servier’s medical liaison specialist emails “softened the market” for ivabradine in heart failure. Appeal Board upheld breaches for…
A hospital pharmacist alleged Celgene’s Vidaza advisory boards (incl. £600 honorarium) were disguised promotion/inducement around SMC timing. PMCPA found legitimate consultancy need,…
BMJ analysis suggested Novo Nordisk had 1 “due” EUCTR trial without posted results (98.1% compliance). Company said the trial was withdrawn before…
PMCPA case AUTH/3076/9/18 (Director v AstraZeneca) about clinical trial disclosure. The matter was ruled outwith the scope of the ABPI Code (2016).…
A doctor challenged a third‑party invitation to a paid “training day research” workshop for rep mock consultations. Panel initially found disguised promotion,…
Anonymous physician alleged a ProStrakan rep gave an incorrect day-by-day Abstral titration schedule. Panel found the complaint unproven on the balance of…
Novo Nordisk alleged a PCDS satellite symposium promoted unlicensed dapagliflozin and that sales reps attended. The Panel found the complaint not proven…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.